Pacemaker Market Analysis, Size, Trends | Global | 2019-2025 | MedCore
- Year: 2020
- Scope: 2015-2025
- Region: Africa, Middle East, North America, Asia-Pacific, Europe, Latin America
- Pages: 252
- Published Date: 11/09/2020
- Type: MedCore
By 2020, the global pacemaker market size was valued at $2.26 billion, with over 450,000 pacemaker procedures performed annually. The market size is expected to further increase over the forecast period and reach $2.6 billion in 2025.
Throughout this medical market research, we analyzed global pacemaker companies across more than 70 countries and used our comprehensive methodology to understand the market sizes, unit sales, company market shares, and to create accurate forecasts.
Our analysts meticulously researched for up to 3 to 4 months to put together a Global Cardiac Rhythm Management Device MedSuite, which is a comprehensive analysis of a group of healthcare markets. This MedCore is one portion of that analysis that focuses on the Pacemaker market segment and provides further detailed segmentation to get a much more granular set of market data.
DATA TYPES INCLUDED
- Unit Sales, Average Selling Prices, Market Value & Growth Trends
- Pacemaker Procedure Volumes
- Market Forecasts Until 2025, and Historical Data to 2015
- Market Drivers & Limiters for Each Pacemaker market
- Competitive Analysis with Market Shares for Each Segment
- Recent Mergers & Acquisitions
- Disease Overviews and Demographic Information
- Company Profiles, Product Portfolios, and SWOT for Top Competitors
Pacemaker Market Insights
New technologies are constantly emerging in the cardiac rhythm management and ablation market. The capabilities and battery lifespan of pacemakers have increased in the last decade. Over the forecast period, wireless technology is expected to make it easier for doctors to maintain and adjust pacemaker function. In addition, new technologies are expected to keep selling prices high and lead to a higher number of devices sold.
The United States is the dominant market for Pacemakers with a total market value expected to reach $2 billion in 2025. However, a tight competitive landscape signals a slowdown in growth rates for the American market. Europe is the second-largest market for Pacemakers with a total market value expected to reach €411 million in 2025. Adoption for leadless pacemaker devices is slow in the E.U. therefore impacting the overall growth rates.
Pacemaker Market Share Insights
By 2020, Medtronic led the pacemaker market with single-chamber, dual-chamber, and leadless devices. Medtronic pioneered the development of pacemakers and has long been the leading manufacturer in the pacemaker market.
Abbott was the second-leading competitor in the Global Pacemaker market by 2020. Abbott entered the market in 2017 with the complete acquisition of St. Jude Medical. The company has a very competitive pricing model and leverages off relationships from its electrophysiology and cardiac ablation business to gain more accounts within the CRM market.
Report Regional Coverage
Throughout this research series, iData Research has covered several regions in great detail. Each region may be purchased as a stand-alone report, tailoring the data to your needs. The regions covered are:
- North America (the United States and Canada)
- Latin America (Brazil, Mexico, Colombia, Argentina, Peru, Chile, Venezuela, and Other)
- Western Europe (Germany, France, Italy, Spain, Switzerland, Austria, Portugal, Benelux, Scandinavia, and Other)
- Central and Eastern Europe (Poland, Turkey, Russia, Greece, Czech Republic, Croatia, Bulgaria, Ukraine, Kazakhstan, Hungary, Romania, Baltic States (Estonia, Latvia, and Lithuania), and Other)
- Middle East (Saudi Arabia, UAE, Israel, Iran, Kuwait, Qatar, Bahrain, Oman, and Other)
- Asia Pacific (China, Japan, South Korea, India, Australia, Singapore, Indonesia, Malaysia, Thailand, the Philippines, Brunei, Myanmar, Cambodia, Vietnam, New Zealand, Taiwan, Hong Kong, and Other)
- Africa (South Africa, Egypt, Morocco, Ghana, Nigeria, Libya, Sudan, Uganda, Kenya, and Other)
Pacemaker Market Segmentation
DON’T SEE THE SEGMENT OR DATA YOU NEED?
Feel free to contact us or send a request by pressing one of the buttons below.
TABLE OF CONTENTS FOR GLOBAL PACEMAKER REPORT SUITETABLE OF CONTENTS ILIST OF FIGURES XILIST OF CHARTS XVIEXECUTIVE SUMMARY 1GLOBAL PACEMAKER MARKET OVERVIEW 1COMPETITIVE ANALYSIS 4MARKET TRENDS 7MARKET DEVELOPMENTS 8PROCEDURE NUMBERS 8MARKETS INCLUDED 9REGIONS INCLUDED 10VERSION HISTORY 12RESEARCH METHODOLOGY 13Step 1: Project Initiation & Team Selection 13Step 2: Prepare Data Systems and Perform Secondary Research 16Step 3: Preparation for Interviews & Questionnaire Design 18Step 4: Performing Primary Research 19Step 5: Research Analysis: Establishing Baseline Estimates 21Step 6: Market Forecast and Analysis 22Step 7: Identify Strategic Opportunities 24Step 8: Final Review and Market Release 25Step 9: Customer Feedback and Market Monitoring 26
DISEASE OVERVIEW2.1 INTRODUCTION 272.2 TYPES OF ARRHYTHMIAS 282.2.1 Atrial Fibrillation 282.2.2 Bradycardia 292.2.3 Conduction Disorders 2220.127.116.11 Bundle Branch Block 218.104.22.168 Heart Block 302.2.3.3 Long QT Syndrome (LQTS) 312.2.4 Premature Contractions: PACs and PVCs 312.2.5 Tachycardia 322.2.6 Ventricular Fibrillation 322.2.7 Other Rhythm Disorders 322.214.171.124 Adams-Stokes Disease 3126.96.36.199 Atrial Flutter 3188.8.131.52 Sick Sinus syndrome 3184.108.40.206 Sinus Arrhythmia 3220.127.116.11 Wolff-Parkinson-White Syndrome (WPW) 342.2.8 Types of Arrhythmia in Children 342.3 HEART FAILURE 342.4 CARDIAC ARREST 352.5 PATIENT DEMOGRAPHICS 372.5.1 Atrial Fibrillation 372.5.2 Bradycardia 372.5.3 Conduction Disorders 382.5.4 Premature Contractions – PACs and PVCs 392.5.5 Tachycardia 402.5.6 Ventricular Fibrillation 402.5.7 Other Rhythm Disorders 41
PRODUCT ASSESSMENT3.1 INTRODUCTION 423.2 PRODUCT PORTFOLIOS 423.2.1 Pacemakers 423.3 FDA RECALLS 453.3.1 Abbott 453.3.2 Boston Scientific 463.3.3 Medtronic 523.4 CLINICAL TRIALS 533.4.1 Pacemakers 53
GLOBAL PACEMAKER MARKET OVERVIEW4.1 INTRODUCTION 584.1.1 Single and Dual-Chamber Devices 584.1.2 MRI-Compatible Pacemaker 594.1.3 Leadless Pacemaker 594.1.4 Initial Placement and Replacement of Pacemakers 604.2 MARKET OVERVIEW 614.3 TREND ANALYSIS BY SEGMENT 664.4 DRIVERS AND LIMITERS 694.4.1 Market Drivers 694.4.2 Market Limiters 704.5 COMPETITIVE MARKET SHARE ANALYSIS 734.6 MERGERS AND ACQUISITIONS 774.7 COMPANY PROFILES 784.7.1 Abbott 784.7.2 Biosense Webster 794.7.3 Biotronik 804.7.4 Boston Scientific 814.7.5 Cardiac Science 834.7.6 GE Healthcare 844.7.7 Medtronic 854.7.8 MicroPort 864.7.9 ZOLL 884.8 SWOT ANALYSIS 894.8.1 Abbott 894.8.2 Biosense Webster 914.8.3 Biotronik 924.8.4 Boston Scientific 934.8.5 Cardiac Science 944.8.6 GE Healthcare 954.8.7 Medtronic 964.8.8 MicroPort 974.8.9 ZOLL 99
PROCEDURE NUMBERS5.1 INTRODUCTION 1005.2 PROCEDURES 1015.2.1 Global Procedures 1015.2.2 North America Procedures 1035.2.2.1 Canada 1055.2.2.2 U.S. 1055.2.3 Latin America Procedures 1065.2.3.1 Argentina 1085.2.3.2 Brazil 1085.2.3.3 Chile 1085.2.3.4 Colombia 1095.2.3.5 Jamaica 1095.2.3.6 Mexico 118.104.22.168 Peru 122.214.171.124 Venezuela 1126.96.36.199 Rest of Latin America 1115.2.4 Western Europe Procedures 1188.8.131.52 Austria 1184.108.40.206 Benelux 1220.127.116.11 France 118.104.22.168 Germany 122.214.171.124 Italy 1126.96.36.199 Portugal 1188.8.131.52 Scandinavia 1184.108.40.206 Spain 1220.127.116.11 Switzerland 118.104.22.168 United Kingdom 122.214.171.124 Rest of Western Europe 1195.2.5 Central & Eastern Europe Procedures 1126.96.36.199 Baltic States 1188.8.131.52 Bulgaria 1184.108.40.206 Croatia 1220.127.116.11 Czech Republic 118.104.22.168 Greece 122.214.171.124 Hungary 1245.2.5.7 Kazakhstan 1245.2.5.8 Poland 1255.2.5.9 Romania 1255.2.5.10 Russia 1255.2.5.11 Turkey 12126.96.36.199 Ukraine 12188.8.131.52 Rest of Central & Eastern Europe 1275.2.6 Middle East Procedures 12184.108.40.206 Bahrain 1305.2.6.2 Iran 1305.2.6.3 Israel 1305.2.6.4 Kuwait 13220.127.116.11 Oman 1318.104.22.168 Qatar 1322.214.171.124 Saudi Arabia 13126.96.36.199 United Arab Emirates 13188.8.131.52 Rest of Middle East 1335.2.7 Asia-Pacific Procedures 13184.108.40.206 Australia 13220.127.116.11 Brunei 1318.104.22.168 Cambodia 1322.214.171.124 China 13126.96.36.199 Hong Kong 13188.8.131.52 India 13184.108.40.206 Indonesia 13220.127.116.11 Japan 1405.2.7.9 Malaysia 1405.2.7.10 Myanmar 1405.2.7.11 New Zealand 1418.104.22.168 Singapore 1422.214.171.124 South Korea 14126.96.36.199 Taiwan 14188.8.131.52 Thailand 14184.108.40.206 The Philippines 14220.127.116.11 Vietnam 1418.104.22.168 Rest of Asia Pacific 1445.2.8 Africa Procedures 1422.214.171.124 Algeria 14126.96.36.199 Egypt 14188.8.131.52 Ghana 14184.108.40.206 Kenya 14220.127.116.11 Libya 1418.104.22.168 Morocco 1422.214.171.124 Nigeria 14126.96.36.199 South Africa 1505.2.8.9 Sudan 1505.2.8.10 Uganda 1505.2.8.11 Rest of Africa 151
NORTH AMERICA MARKET6.1 INTRODUCTION 1526.1.1 Single and Dual-Chamber Devices 1526.1.2 MRI-Compatible Pacemaker 1536.1.3 Initial Placement and Replacement of Pacemakers 1536.1.4 Countries Included 1546.2 MARKET OVERVIEW 1556.2.1 Total Single-Chamber Pacemaker Market 15188.8.131.52 New Placement Single-Chamber Pacemaker Market 1606.2.1.2 Replacement Single-Chamber Pacemaker Market 1616.2.2 Total Dual-Chamber Pacemaker Market 16184.108.40.206 New Placement Dual-Chamber Pacemaker Market 16220.127.116.11 Replacement Dual-Chamber Pacemaker Market 165
LATIN AMERICA MARKET7.1 INTRODUCTION 1677.1.1 Single and Dual-Chamber Devices 1677.1.2 MRI-Compatible Pacemaker 1687.1.3 Initial Placement and Replacement of Pacemakers 1687.1.4 Countries Included 1697.2 MARKET OVERVIEW 1707.2.1 Total Single-Chamber Pacemaker Market 1718.104.22.168 New Placement Single-Chamber Pacemaker Market 1722.214.171.124 Replacement Single-Chamber Pacemaker Market 1767.2.2 Total Dual-Chamber Pacemaker Market 17126.96.36.199 New Placement Dual-Chamber Pacemaker Market 17188.8.131.52 Replacement Dual-Chamber Pacemaker Market 180
WESTERN EUROPE MARKET8.1 INTRODUCTION 1818.1.1 Single and Dual-Chamber Devices 1818.1.2 MRI-Compatible Pacemaker 1828.1.3 Initial Placement and Replacement of Pacemakers 1828.1.4 Countries Included 1838.2 MARKET OVERVIEW 1848.2.1 Total Single-Chamber Pacemaker Market 18184.108.40.206 New Placement Single-Chamber Pacemaker Market 18220.127.116.11 Replacement Single-Chamber Pacemaker Market 1908.2.2 Total Dual-Chamber Pacemaker Market 1918.104.22.168 New Placement Dual-Chamber Pacemaker Market 1922.214.171.124 Replacement Dual-Chamber Pacemaker Market 194
CENTRAL & EASTERN EUROPE MARKET9.1 INTRODUCTION 1959.1.1 Single and Dual-Chamber Devices 1959.1.2 MRI-Compatible Pacemaker 1969.1.3 Initial Placement and Replacement of Pacemakers 1969.1.4 Countries Included 1979.2 MARKET OVERVIEW 1989.2.1 Total Single-Chamber Pacemaker Market 2019.2.1.1 New Placement Single-Chamber Pacemaker Market 2039.2.1.2 Replacement Single-Chamber Pacemaker Market 2049.2.2 Total Dual-Chamber Pacemaker Market 2059.2.2.1 New Placement Dual-Chamber Pacemaker Market 2079.2.2.2 Replacement Dual-Chamber Pacemaker Market 208
MIDDLE EAST MARKET10.1 INTRODUCTION 20910.1.1 Single and Dual-Chamber Devices 20910.1.2 MRI-Compatible Pacemaker 21010.1.3 Initial Placement and Replacement of Pacemakers 21010.1.4 Countries Included 21110.2 MARKET OVERVIEW 21210.2.1 Total Single-Chamber Pacemaker Market 21510.2.1.1 New Placement Single-Chamber Pacemaker Market 21710.2.1.2 Replacement Single-Chamber Pacemaker Market 21810.2.2 Total Dual-Chamber Pacemaker Market 21910.2.2.1 New Placement Dual-Chamber Pacemaker Market 22126.96.36.199 Replacement Dual-Chamber Pacemaker Market 222For a Full Table of Contents, please contact iData.
- Boston Scientific
- Lepu Medical
- Osypka Medical
- MEDICO S.P.A
iData’s 9-Step Research MethodologyOur reports follow an in-depth 9-step methodology which focuses on the following research systems:
- Original primary research that consists of the most up-to-date market data
- Strong foundation of quantitative and qualitative research
- Focused on the needs and strategic challenges of the industry participants
Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.
Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.
Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.
Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.
Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.
Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.
Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.
Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.
Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.